Biotech, one of the Bay Area's most important industries, sprang up in five short decades. Here are the key moments to know ...

CRISPR Therapeutics partnered with big biotech Vertex Pharmaceuticals ( VRTX 3.40%) on Casgevy. Although Vertex takes a ...

The American Society of Gene and Cell Therapy (ASGCT) meeting is off and running in New Orleans! Kevin Davies, PhD, editorial director and Julianna LeMieux, PhD, deputy editor in chief at GEN are on ...

Rocket Pharmaceuticals has shared early data from three patients that tie its gene therapy for an inherited heart disease to ...

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving insulin.

According to Yee, the sector is facing several challenges that have caused significant pressure and anxiety among biotech investors. One of them is definitely sector-specific tariffs. The 50% ...

The Biotechnology Program has also expanded its STEM outreach efforts to include a summer internship program for high school ...

The one-off treatment highlights the promise of a new type of gene editing and the challenges of using it to treat extremely ...

Stylus Medicine is unsheathing, penning a mission to develop next-gen in vivo genetic medicines with $85 million in hand, ...

At stake in the ongoing patent dispute over the gene-editing tool are rights to the most important new biotechnology of the ...

According to Yee, the sector is facing several challenges that have caused significant pressure and anxiety among biotech investors. One of them is definitely sector-specific tariffs. The 50% ...

Tsingke Biotech proudly participated in the AACR Annual Meeting 2025, held this April in Chicago, USA. As one of the world's premier events in oncology research, AACR gathered global leaders from ...